If You Take A GLP-1 Medicine And Have Been Hospitalised By Acute Pancreatitis, The Yellow Card Biobank Wants To Hear From You
The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will start investigating whether the risk of acute pancreatitis (inflamed pancreas) from GLP-1 injections for weight loss and Type 2 diabetes may be influenced by an individual’s genes. Patients who have…